#competitive-intel
Competitor launches, congress data
C07CINTEL08
501 msgs in channel · showing recent 250 + 2 storyline
JP
Jordan PatelThu Sep 25, 3:00 PMarc: asco-readout
Tagrisso adjuvant amendment — limited overlap with our 1L PD-L1 indication. Watch share-shift. — Jordan files a one-pager in #competitive-intel. Frames the impact as 'second-line risk' (post-adjuvant relapse). Doesn't model the mixed-biomarker share-shift effect at 1L.
DP
Dana ParkFri Nov 14, 3:57 PM
Patent expiry watch: Tecentriq loses exclusivity Nov 3.
JP
Jordan PatelSat Nov 15, 1:22 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuSat Nov 15, 2:06 PM
Patent expiry watch: Tecentriq loses exclusivity Nov 10.
KW
Karen WuSat Nov 15, 3:40 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
DP
Dana ParkWed Nov 19, 5:12 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 34.
JP
Jordan PatelThu Nov 19, 7:44 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
KW
Karen WuThu Nov 19, 8:19 PM
Need a one-pager on the DESTINY-Lung01 readout by EOD Thu.
JP
Jordan PatelThu Nov 20, 2:34 PM
BMS pipeline-day deck out — slide 18 on NSCLC strategy.
KW
Karen WuThu Nov 20, 5:42 PM
Pharma 50 leaderboard refresh — moved up 28 spots.
JP
Jordan PatelThu Nov 20, 5:53 PM
Patent expiry watch: Enhertu loses exclusivity Nov 17.
DP
Dana ParkFri Nov 21, 4:35 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
DP
Dana ParkSat Nov 22, 4:11 PM
Daiichi adcomm on Opdivo — outcome favorable.
DP
Dana ParkSat Nov 22, 4:56 PM
Trial readout calendar updated — pinned in this channel.
MR
Marco ReyesWed Nov 25, 8:45 PM
BMS new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelWed Nov 26, 11:19 AM
Need a one-pager on the FLAURA-2 readout by EOD Thu.
JP
Jordan PatelWed Nov 26, 3:11 PM
Daiichi adcomm on Keytruda — outcome favorable.
KW
Karen WuWed Nov 26, 3:16 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
KW
Karen WuThu Nov 27, 3:01 PM
Trial readout calendar updated — pinned in this channel.
JP
Jordan PatelFri Nov 28, 2:15 PM
Patent expiry watch: Tecentriq loses exclusivity Nov 17.
KW
Karen WuFri Nov 28, 5:27 PM
AstraZeneca Q3 earnings call — Keytruda guidance up 105%.
KW
Karen WuSat Nov 29, 12:50 PM
Pharma 50 leaderboard refresh — moved up 7 spots.
DP
Dana ParkMon Dec 1, 5:40 PM
Pharma 50 leaderboard refresh — moved up 44 spots.
KW
Karen WuWed Dec 2, 8:32 PM
Merck new ISI campaign launched — saw it on LinkedIn this morning.
DP
Dana ParkWed Dec 3, 1:36 PM
FDA briefing doc for Tagrisso AdCom posted — first read coming.
JP
Jordan PatelWed Dec 3, 6:30 PM
Patent expiry watch: Enhertu loses exclusivity Nov 22.
KW
Karen WuThu Dec 3, 7:16 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 58.
MR
Marco ReyesFri Dec 4, 7:59 PM
FDA briefing doc for Tecentriq AdCom posted — first read coming.
DP
Dana ParkMon Dec 8, 12:30 PM
Patent expiry watch: Keytruda loses exclusivity Nov 18.
DP
Dana ParkMon Dec 8, 3:29 PM
Daiichi adcomm on Tecentriq — outcome favorable.
JP
Jordan PatelTue Dec 9, 4:15 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelWed Dec 9, 7:07 PM
ClinicalTrials.gov posted new FLAURA-2 arm — patient count 73.
KW
Karen WuWed Dec 9, 8:32 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuThu Dec 11, 12:26 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
MR
Marco ReyesSat Dec 12, 8:33 PM
BMS pipeline-day deck out — slide 36 on NSCLC strategy.
DP
Dana ParkSat Dec 13, 12:38 PM
BMS pipeline-day deck out — slide 31 on NSCLC strategy.
MR
Marco ReyesSun Dec 14, 5:49 PM
BMS new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelTue Dec 16, 3:21 PM
BMS pipeline-day deck out — slide 42 on NSCLC strategy.
MR
Marco ReyesWed Dec 16, 8:01 PM
AstraZeneca Q3 earnings call — Enhertu guidance up 80%.
JP
Jordan PatelWed Dec 17, 4:54 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelThu Dec 17, 8:27 PM
BMS pipeline-day deck out — slide 60 on NSCLC strategy.
DP
Dana ParkFri Dec 19, 6:52 PM
Patent expiry watch: Tagrisso loses exclusivity Dec 2.
MR
Marco ReyesSat Dec 20, 3:24 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelTue Dec 22, 8:43 PM
Need a one-pager on the CheckMate-816 readout by EOD Thu.
MR
Marco ReyesTue Dec 23, 4:19 PM
Pharma 50 leaderboard refresh — moved up 54 spots.
DP
Dana ParkThu Dec 25, 4:53 PM
Need a one-pager on the CheckMate-816 readout by EOD Thu.
JP
Jordan PatelThu Dec 25, 5:29 PM
Pharma 50 leaderboard refresh — moved up 34 spots.
MR
Marco ReyesFri Dec 25, 7:07 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesSat Dec 26, 7:18 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesSat Dec 27, 11:15 AM
Patent expiry watch: Enhertu loses exclusivity Dec 13.
DP
Dana ParkSat Dec 27, 3:16 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesSat Dec 27, 5:53 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
MR
Marco ReyesSun Dec 27, 7:20 PM
Trial readout calendar updated — pinned in this channel.
MR
Marco ReyesTue Dec 30, 5:07 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
MR
Marco ReyesTue Dec 30, 5:27 PM
Patent expiry watch: Enhertu loses exclusivity Dec 18.
KW
Karen WuWed Dec 31, 1:07 PM
Need a one-pager on the CheckMate-816 readout by EOD Thu.
MR
Marco ReyesWed Dec 31, 1:38 PM
Daiichi CheckMate-816 abstract dropped — Kaplan-Meier at 33mo.
DP
Dana ParkThu Jan 1, 4:46 PM
AstraZeneca Q4 earnings call — Tecentriq guidance up 83%.
MR
Marco ReyesThu Jan 1, 6:10 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
DP
Dana ParkSat Jan 2, 8:28 PM
Trial readout calendar updated — pinned in this channel.
DP
Dana ParkSat Jan 3, 3:55 PM
BMS pipeline-day deck out — slide 14 on NSCLC strategy.
JP
Jordan PatelSun Jan 4, 6:56 PM
FDA briefing doc for Keytruda AdCom posted — first read coming.
KW
Karen WuWed Jan 6, 7:22 PM
BMS new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelThu Jan 8, 2:30 PM
BMS pipeline-day deck out — slide 33 on NSCLC strategy.
DP
Dana ParkThu Jan 8, 3:43 PM
BMS pipeline-day deck out — slide 57 on NSCLC strategy.
DP
Dana ParkThu Jan 8, 4:35 PM
Pharma 50 leaderboard refresh — moved up 69 spots.
MR
Marco ReyesFri Jan 8, 7:12 PM
ClinicalTrials.gov posted new FLAURA-2 arm — patient count 81.
KW
Karen WuSat Jan 10, 11:51 AM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesSat Jan 10, 1:30 PM
Daiichi adcomm on Enhertu — outcome favorable.
JP
Jordan PatelTue Jan 13, 2:10 PM
Pharma 50 leaderboard refresh — moved up 8 spots.
DP
Dana ParkTue Jan 13, 4:04 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuWed Jan 14, 3:37 PM
FDA briefing doc for Tecentriq AdCom posted — first read coming.
MR
Marco ReyesWed Jan 14, 5:11 PM
BMS pipeline-day deck out — slide 52 on NSCLC strategy.
DP
Dana ParkThu Jan 15, 4:09 PM
Roche new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelSat Jan 16, 7:52 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuTue Jan 20, 1:33 PM
Need a one-pager on the DESTINY-Lung01 readout by EOD Thu.
MR
Marco ReyesTue Jan 20, 3:58 PM
AstraZeneca Q4 earnings call — Tecentriq guidance up 101%.
JP
Jordan PatelWed Jan 20, 8:13 PM
ClinicalTrials.gov posted new FLAURA-2 arm — patient count 35.
KW
Karen WuWed Jan 21, 3:53 PM
AstraZeneca Q4 earnings call — Keytruda guidance up 108%.
MR
Marco ReyesWed Jan 21, 5:57 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 48.
JP
Jordan PatelThu Jan 22, 1:04 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
JP
Jordan PatelSun Jan 24, 8:47 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
DP
Dana ParkMon Jan 26, 1:42 PM
ClinicalTrials.gov posted new KEYNOTE-189 arm — patient count 19.
JP
Jordan PatelWed Jan 27, 7:48 PM
Pharma 50 leaderboard refresh — moved up 52 spots.
DP
Dana ParkWed Jan 28, 12:01 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelWed Jan 28, 12:30 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
DP
Dana ParkThu Jan 29, 2:06 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
JP
Jordan PatelFri Jan 29, 7:45 PM
ClinicalTrials.gov posted new DESTINY-Lung01 arm — patient count 7.
JP
Jordan PatelFri Jan 30, 6:24 PM
ClinicalTrials.gov posted new IMpower133 arm — patient count 63.
JP
Jordan PatelSat Jan 30, 8:51 PM
Daiichi adcomm on Tecentriq — outcome favorable.
DP
Dana ParkTue Feb 3, 1:48 PM
AstraZeneca FLAURA-2 abstract dropped — Kaplan-Meier at 17mo.
JP
Jordan PatelTue Feb 3, 5:07 PM
FDA briefing doc for Tecentriq AdCom posted — first read coming.
JP
Jordan PatelWed Feb 4, 3:39 PM
Patent expiry watch: Enhertu loses exclusivity Jan 23.
JP
Jordan PatelFri Feb 5, 8:29 PM
AstraZeneca Q4 earnings call — Tecentriq guidance up 117%.
KW
Karen WuFri Feb 6, 3:52 PM
ClinicalTrials.gov posted new KEYNOTE-189 arm — patient count 48.
DP
Dana ParkFri Feb 6, 6:31 PM
Pharma 50 leaderboard refresh — moved up 21 spots.
DP
Dana ParkSun Feb 8, 4:05 PM
Merck IMpower133 abstract dropped — Kaplan-Meier at 40mo.
KW
Karen WuTue Feb 10, 2:12 PM
Patent expiry watch: Tagrisso loses exclusivity Jan 28.
MR
Marco ReyesTue Feb 10, 3:09 PM
Roche CheckMate-816 abstract dropped — Kaplan-Meier at 8mo.
MR
Marco ReyesTue Feb 10, 4:10 PM
Need a one-pager on the FLAURA-2 readout by EOD Thu.
KW
Karen WuTue Feb 10, 5:29 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuThu Feb 12, 12:28 PM
Patent expiry watch: Keytruda loses exclusivity Jan 28.
MR
Marco ReyesThu Feb 12, 1:10 PM
Merck IMpower133 abstract dropped — Kaplan-Meier at 10mo.
JP
Jordan PatelThu Feb 12, 3:11 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesThu Feb 12, 6:44 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
DP
Dana ParkTue Feb 17, 5:45 PM
Need a one-pager on the IMpower133 readout by EOD Thu.
MR
Marco ReyesWed Feb 17, 7:37 PM
Patent expiry watch: Tagrisso loses exclusivity Feb 11.
DP
Dana ParkWed Feb 18, 5:14 PM
Pharma 50 leaderboard refresh — moved up 25 spots.
DP
Dana ParkWed Feb 18, 5:48 PM
BMS pipeline-day deck out — slide 61 on NSCLC strategy.
KW
Karen WuThu Feb 19, 4:13 PM
BMS pipeline-day deck out — slide 21 on NSCLC strategy.
DP
Dana ParkFri Feb 20, 2:07 PM
Pharma 50 leaderboard refresh — moved up 69 spots.
KW
Karen WuFri Feb 20, 3:36 PM
Patent expiry watch: Keytruda loses exclusivity Feb 16.
JP
Jordan PatelFri Feb 20, 5:41 PM
AstraZeneca Q4 earnings call — Keytruda guidance up 115%.
MR
Marco ReyesSat Feb 21, 11:26 AM
AstraZeneca Q4 earnings call — Tagrisso guidance up 82%.
KW
Karen WuSat Feb 21, 11:50 AM
FDA briefing doc for Tagrisso AdCom posted — first read coming.
MR
Marco ReyesTue Feb 24, 3:08 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
MR
Marco ReyesWed Feb 25, 2:52 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
DP
Dana ParkThu Feb 26, 1:11 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelFri Feb 27, 4:19 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
KW
Karen WuSat Feb 27, 8:31 PM
BMS pipeline-day deck out — slide 36 on NSCLC strategy.
DP
Dana ParkSat Feb 28, 12:20 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesSat Feb 28, 1:07 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 69.
DP
Dana ParkTue Mar 3, 2:38 PM
Daiichi adcomm on Tagrisso — outcome favorable.
DP
Dana ParkWed Mar 3, 7:42 PM
AstraZeneca new ISI campaign launched — saw it on LinkedIn this morning.
KW
Karen WuWed Mar 4, 6:58 PM
Patent expiry watch: Tecentriq loses exclusivity Feb 25.
JP
Jordan PatelThu Mar 5, 4:52 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
KW
Karen WuFri Mar 5, 8:37 PM
Need a one-pager on the FLAURA-2 readout by EOD Thu.
JP
Jordan PatelFri Mar 6, 11:17 AM
Roche IMpower133 abstract dropped — Kaplan-Meier at 78mo.
DP
Dana ParkFri Mar 6, 12:33 PM
Patent expiry watch: Keytruda loses exclusivity Feb 28.
MR
Marco ReyesFri Mar 6, 3:30 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelSat Mar 6, 8:27 PM
Trial readout calendar updated — pinned in this channel.
MR
Marco ReyesSat Mar 7, 2:15 PM
Trial readout calendar updated — pinned in this channel.
JP
Jordan PatelTue Mar 10, 4:32 PM
ClinicalTrials.gov posted new KEYNOTE-189 arm — patient count 39.
DP
Dana ParkTue Mar 10, 5:17 PM
Daiichi KEYNOTE-189 abstract dropped — Kaplan-Meier at 80mo.
JP
Jordan PatelTue Mar 10, 7:53 PM
Need a one-pager on the DESTINY-Lung01 readout by EOD Thu.
JP
Jordan PatelWed Mar 11, 2:47 PM
Trial readout calendar updated — pinned in this channel.
DP
Dana ParkWed Mar 11, 5:46 PM
AstraZeneca KEYNOTE-189 abstract dropped — Kaplan-Meier at 5mo.
JP
Jordan PatelThu Mar 12, 2:41 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelThu Mar 12, 3:27 PM
Need a one-pager on the IMpower133 readout by EOD Thu.
JP
Jordan PatelFri Mar 12, 8:50 PM
Daiichi adcomm on Enhertu — outcome favorable.
DP
Dana ParkSat Mar 14, 6:35 PM
ClinicalTrials.gov posted new IMpower133 arm — patient count 30.
KW
Karen WuTue Mar 17, 4:27 PM
Daiichi KEYNOTE-189 abstract dropped — Kaplan-Meier at 40mo.
KW
Karen WuWed Mar 18, 12:09 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelWed Mar 18, 3:27 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
KW
Karen WuWed Mar 18, 3:35 PM
Need a one-pager on the FLAURA-2 readout by EOD Thu.
MR
Marco ReyesThu Mar 19, 1:46 PM
Merck FLAURA-2 abstract dropped — Kaplan-Meier at 11mo.
KW
Karen WuFri Mar 19, 9:35 PM
Pharma 50 leaderboard refresh — moved up 42 spots.
DP
Dana ParkMon Mar 23, 5:22 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelTue Mar 24, 12:02 PM
Trial readout calendar updated — pinned in this channel.
DP
Dana ParkTue Mar 24, 12:08 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
JP
Jordan PatelTue Mar 24, 7:45 PM
Pharma 50 leaderboard refresh — moved up 28 spots.
JP
Jordan PatelThu Mar 26, 1:29 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 51.
DP
Dana ParkThu Mar 26, 3:44 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelFri Mar 27, 12:05 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
KW
Karen WuFri Mar 27, 1:18 PM
Trial readout calendar updated — pinned in this channel.
MR
Marco ReyesFri Mar 27, 4:19 PM
Need a one-pager on the CheckMate-816 readout by EOD Thu.
MR
Marco ReyesSun Mar 28, 9:41 PM
Pharma 50 leaderboard refresh — moved up 14 spots.
MR
Marco ReyesTue Mar 31, 4:37 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuWed Apr 1, 5:53 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 81.
DP
Dana ParkThu Apr 1, 8:40 PM
Daiichi adcomm on Keytruda — outcome favorable.
KW
Karen WuThu Apr 1, 9:32 PM
Daiichi adcomm on Tagrisso — outcome favorable.
KW
Karen WuThu Apr 2, 12:53 PM
AstraZeneca CheckMate-816 abstract dropped — Kaplan-Meier at 46mo.
KW
Karen WuMon Apr 6, 6:04 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
DP
Dana ParkTue Apr 7, 1:06 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesWed Apr 8, 4:22 PM
Patent expiry watch: Enhertu loses exclusivity Apr 1.
KW
Karen WuThu Apr 9, 4:03 PM
AstraZeneca Q5 earnings call — Opdivo guidance up 87%.
MR
Marco ReyesFri Apr 10, 12:38 PM
FDA briefing doc for Tecentriq AdCom posted — first read coming.
DP
Dana ParkFri Apr 10, 3:43 PM
AstraZeneca Q5 earnings call — Enhertu guidance up 90%.
JP
Jordan PatelSat Apr 10, 8:40 PM
ClinicalTrials.gov posted new FLAURA-2 arm — patient count 33.
KW
Karen WuSun Apr 11, 8:40 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
MR
Marco ReyesMon Apr 13, 12:05 PM
Patent expiry watch: Tecentriq loses exclusivity Apr 2.
KW
Karen WuTue Apr 14, 6:05 PM
Need a one-pager on the CheckMate-816 readout by EOD Thu.
DP
Dana ParkWed Apr 15, 2:37 PM
Daiichi adcomm on Keytruda — outcome favorable.
DP
Dana ParkThu Apr 16, 6:31 PM
BMS DESTINY-Lung01 abstract dropped — Kaplan-Meier at 77mo.
KW
Karen WuFri Apr 17, 12:25 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelFri Apr 17, 3:32 PM
Patent expiry watch: Enhertu loses exclusivity Apr 1.
MR
Marco ReyesFri Apr 17, 6:04 PM
AstraZeneca new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelTue Apr 20, 9:53 PM
Need a one-pager on the KEYNOTE-189 readout by EOD Thu.
KW
Karen WuTue Apr 21, 2:08 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
JP
Jordan PatelWed Apr 21, 8:29 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
DP
Dana ParkWed Apr 21, 8:34 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuWed Apr 21, 8:36 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuWed Apr 22, 2:50 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuFri Apr 24, 1:01 PM
BMS pipeline-day deck out — slide 40 on NSCLC strategy.
KW
Karen WuFri Apr 24, 1:48 PM
AstraZeneca Q5 earnings call — Opdivo guidance up 117%.
KW
Karen WuFri Apr 24, 5:14 PM
BMS pipeline-day deck out — slide 36 on NSCLC strategy.
MR
Marco ReyesSat Apr 25, 7:13 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuTue Apr 28, 2:45 PM
BMS IMpower133 abstract dropped — Kaplan-Meier at 21mo.
KW
Karen WuTue Apr 28, 3:09 PM
Pharma 50 leaderboard refresh — moved up 55 spots.
MR
Marco ReyesThu Apr 30, 12:19 PM
BMS pipeline-day deck out — slide 42 on NSCLC strategy.
DP
Dana ParkThu Apr 30, 2:17 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
DP
Dana ParkThu Apr 30, 6:52 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
DP
Dana ParkFri Apr 30, 9:20 PM
FDA briefing doc for Tagrisso AdCom posted — first read coming.
KW
Karen WuFri May 1, 2:42 PM
Merck IMpower133 abstract dropped — Kaplan-Meier at 30mo.
DP
Dana ParkSat May 2, 4:09 PM
BMS DESTINY-Lung01 abstract dropped — Kaplan-Meier at 28mo.
JP
Jordan PatelTue May 5, 7:20 PM
BMS pipeline-day deck out — slide 3 on NSCLC strategy.
KW
Karen WuWed May 6, 2:41 PM
AstraZeneca Q5 earnings call — Keytruda guidance up 95%.
JP
Jordan PatelWed May 6, 3:20 PM
BMS pipeline-day deck out — slide 31 on NSCLC strategy.
JP
Jordan PatelWed May 6, 5:54 PM
Patent expiry watch: Tagrisso loses exclusivity Apr 29.
KW
Karen WuThu May 7, 2:27 PM
Roche DESTINY-Lung01 abstract dropped — Kaplan-Meier at 56mo.
DP
Dana ParkThu May 7, 6:32 PM
BMS pipeline-day deck out — slide 5 on NSCLC strategy.
JP
Jordan PatelFri May 8, 5:48 PM
Pharma 50 leaderboard refresh — moved up 18 spots.
KW
Karen WuSat May 9, 12:44 PM
Patent expiry watch: Tagrisso loses exclusivity Apr 21.
JP
Jordan PatelSat May 9, 5:17 PM
Trial readout calendar updated — pinned in this channel.
JP
Jordan PatelSat May 9, 7:07 PM
BMS pipeline-day deck out — slide 51 on NSCLC strategy.
JP
Jordan PatelTue May 12, 10:00 AMarc: asco-readout
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6. — Embargo lifts shortly; abstract surface text suggests OS parity with Veltarix/ZENVARA in 1L PD-L1≥50%.
KW
Karen Wu, PharmDTue May 12, 10:12 AM
Hazard ratio CI overlaps ours — not a clean win for them.
DP
Dana ParkadminTue May 12, 11:30 AM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
MR
Marco ReyesTue May 12, 1:36 PM
ClinicalTrials.gov posted new KEYNOTE-189 arm — patient count 69.
MR
Marco ReyesTue May 12, 2:52 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuWed May 13, 7:16 PM
AstraZeneca Q5 earnings call — Opdivo guidance up 80%.
DP
Dana ParkThu May 14, 1:53 PM
Need a one-pager on the FLAURA-2 readout by EOD Thu.
KW
Karen WuFri May 15, 12:23 PM
Need a one-pager on the CheckMate-816 readout by EOD Thu.
DP
Dana ParkFri May 15, 5:07 PM
AstraZeneca Q5 earnings call — Tagrisso guidance up 88%.
DP
Dana ParkTue May 19, 4:34 PM
BMS KEYNOTE-189 abstract dropped — Kaplan-Meier at 70mo.
JP
Jordan PatelThu May 21, 1:32 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelThu May 21, 7:56 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
JP
Jordan PatelFri May 21, 9:47 PM
Daiichi adcomm on Tecentriq — outcome favorable.
DP
Dana ParkFri May 22, 1:50 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
KW
Karen WuFri May 22, 2:39 PM
Daiichi adcomm on Keytruda — outcome favorable.
KW
Karen WuFri May 22, 5:58 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelSat May 22, 9:33 PM
ClinicalTrials.gov posted new CheckMate-816 arm — patient count 18.
JP
Jordan PatelWed May 26, 8:37 PM
FDA briefing doc for Keytruda AdCom posted — first read coming.
MR
Marco ReyesWed May 27, 12:15 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
DP
Dana ParkWed May 27, 12:39 PM
Daiichi new ISI campaign launched — saw it on LinkedIn this morning.
MR
Marco ReyesWed May 27, 7:40 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelThu May 28, 5:23 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuFri May 29, 5:27 PM
BMS pipeline-day deck out — slide 18 on NSCLC strategy.
MR
Marco ReyesSat May 30, 12:17 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
MR
Marco ReyesSat May 30, 5:53 PM
AstraZeneca Q5 earnings call — Tagrisso guidance up 111%.
DP
Dana ParkSun May 30, 8:13 PM
Need a one-pager on the BMS CheckMate readout by EOD Thu.
KW
Karen WuTue Jun 2, 5:52 PM
Trial readout calendar updated — pinned in this channel.
JP
Jordan PatelWed Jun 3, 1:47 PM
Daiichi adcomm on Keytruda — outcome favorable.
JP
Jordan PatelThu Jun 3, 9:05 PM
FDA briefing doc for Tecentriq AdCom posted — first read coming.
JP
Jordan PatelFri Jun 4, 9:00 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelFri Jun 5, 3:12 PM
Merck new ISI campaign launched — saw it on LinkedIn this morning.
JP
Jordan PatelFri Jun 5, 3:59 PM
FDA briefing doc for Enhertu AdCom posted — first read coming.
JP
Jordan PatelFri Jun 5, 7:03 PM
Need a one-pager on the IMpower133 readout by EOD Thu.
KW
Karen WuSat Jun 6, 1:45 PM
Patent expiry watch: Opdivo loses exclusivity May 25.
JP
Jordan PatelSun Jun 6, 9:13 PM
Pharma 50 leaderboard refresh — moved up 23 spots.
JP
Jordan PatelMon Jun 8, 7:59 PM
Daiichi adcomm on Enhertu — outcome favorable.
MR
Marco ReyesWed Jun 9, 8:07 PM
BMS pipeline-day deck out — slide 5 on NSCLC strategy.
DP
Dana ParkWed Jun 10, 2:25 PM
Roche FLAURA-2 abstract dropped — Kaplan-Meier at 27mo.
JP
Jordan PatelWed Jun 10, 6:06 PM
ClinicalTrials.gov posted new KEYNOTE-189 arm — patient count 84.
KW
Karen WuThu Jun 11, 7:33 PM
Trial readout calendar updated — pinned in this channel.
KW
Karen WuFri Jun 12, 7:42 PM
BMS pipeline-day deck out — slide 53 on NSCLC strategy.
DP
Dana ParkSat Jun 12, 8:16 PM
Daiichi adcomm on Enhertu — outcome favorable.
DP
Dana ParkSat Jun 13, 2:39 PM
Trial readout calendar updated — pinned in this channel.
JP
Jordan PatelTue Jun 16, 7:43 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.
JP
Jordan PatelWed Jun 16, 9:51 PM
Daiichi adcomm on Enhertu — outcome favorable.
MR
Marco ReyesWed Jun 17, 1:56 PM
Pharma 50 leaderboard refresh — moved up 28 spots.
DP
Dana ParkWed Jun 17, 6:14 PM
AstraZeneca Q5 earnings call — Tecentriq guidance up 105%.
JP
Jordan PatelFri Jun 19, 5:10 PM
AstraZeneca IMpower133 abstract dropped — Kaplan-Meier at 83mo.
JP
Jordan PatelSat Jun 19, 8:53 PM
Competitor X ASCO abstract dropped — Kaplan-Meier at 18.2 mo, our last cut was 17.6.